nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—ALB—coronary artery disease	0.28	1	CbGaD
Gatifloxacin—ALB—Pitavastatin—coronary artery disease	0.0842	0.19	CbGbCtD
Gatifloxacin—ALB—Valsartan—coronary artery disease	0.0819	0.185	CbGbCtD
Gatifloxacin—ALB—Rosuvastatin—coronary artery disease	0.0621	0.14	CbGbCtD
Gatifloxacin—ALB—Acetylsalicylic acid—coronary artery disease	0.0605	0.136	CbGbCtD
Gatifloxacin—ALB—Captopril—coronary artery disease	0.0597	0.135	CbGbCtD
Gatifloxacin—ALB—Furosemide—coronary artery disease	0.048	0.108	CbGbCtD
Gatifloxacin—ALB—Losartan—coronary artery disease	0.047	0.106	CbGbCtD
Gatifloxacin—Feeling abnormal—Perindopril—coronary artery disease	7.1e-05	0.000327	CcSEcCtD
Gatifloxacin—Headache—Lovastatin—coronary artery disease	7.09e-05	0.000326	CcSEcCtD
Gatifloxacin—Pruritus—Valsartan—coronary artery disease	7.07e-05	0.000326	CcSEcCtD
Gatifloxacin—Arthralgia—Timolol—coronary artery disease	7.07e-05	0.000326	CcSEcCtD
Gatifloxacin—Myalgia—Timolol—coronary artery disease	7.07e-05	0.000326	CcSEcCtD
Gatifloxacin—Chest pain—Timolol—coronary artery disease	7.07e-05	0.000326	CcSEcCtD
Gatifloxacin—Vomiting—Ezetimibe—coronary artery disease	7.06e-05	0.000325	CcSEcCtD
Gatifloxacin—Hypersensitivity—Pravastatin—coronary artery disease	7.05e-05	0.000325	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Perindopril—coronary artery disease	7.05e-05	0.000325	CcSEcCtD
Gatifloxacin—Anxiety—Timolol—coronary artery disease	7.04e-05	0.000324	CcSEcCtD
Gatifloxacin—Angioedema—Lisinopril—coronary artery disease	7.04e-05	0.000324	CcSEcCtD
Gatifloxacin—Pruritus—Olmesartan—coronary artery disease	7.04e-05	0.000324	CcSEcCtD
Gatifloxacin—Decreased appetite—Losartan—coronary artery disease	7.03e-05	0.000324	CcSEcCtD
Gatifloxacin—Abdominal pain—Captopril—coronary artery disease	7.02e-05	0.000323	CcSEcCtD
Gatifloxacin—Body temperature increased—Captopril—coronary artery disease	7.02e-05	0.000323	CcSEcCtD
Gatifloxacin—Dizziness—Simvastatin—coronary artery disease	7e-05	0.000322	CcSEcCtD
Gatifloxacin—Rash—Ezetimibe—coronary artery disease	7e-05	0.000322	CcSEcCtD
Gatifloxacin—Dermatitis—Ezetimibe—coronary artery disease	6.99e-05	0.000322	CcSEcCtD
Gatifloxacin—Confusional state—Ramipril—coronary artery disease	6.99e-05	0.000322	CcSEcCtD
Gatifloxacin—Asthenia—Niacin—coronary artery disease	6.97e-05	0.000321	CcSEcCtD
Gatifloxacin—Headache—Ezetimibe—coronary artery disease	6.95e-05	0.00032	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Ramipril—coronary artery disease	6.93e-05	0.000319	CcSEcCtD
Gatifloxacin—Oedema—Ramipril—coronary artery disease	6.93e-05	0.000319	CcSEcCtD
Gatifloxacin—Vertigo—Lisinopril—coronary artery disease	6.92e-05	0.000319	CcSEcCtD
Gatifloxacin—Constipation—Losartan—coronary artery disease	6.91e-05	0.000318	CcSEcCtD
Gatifloxacin—Syncope—Lisinopril—coronary artery disease	6.91e-05	0.000318	CcSEcCtD
Gatifloxacin—Vomiting—Eplerenone—coronary artery disease	6.91e-05	0.000318	CcSEcCtD
Gatifloxacin—Feeling abnormal—Furosemide—coronary artery disease	6.9e-05	0.000318	CcSEcCtD
Gatifloxacin—Nausea—Fenofibrate—coronary artery disease	6.88e-05	0.000317	CcSEcCtD
Gatifloxacin—Pruritus—Niacin—coronary artery disease	6.87e-05	0.000317	CcSEcCtD
Gatifloxacin—Asthenia—Pravastatin—coronary artery disease	6.86e-05	0.000316	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Furosemide—coronary artery disease	6.85e-05	0.000315	CcSEcCtD
Gatifloxacin—Rash—Eplerenone—coronary artery disease	6.85e-05	0.000315	CcSEcCtD
Gatifloxacin—Urticaria—Perindopril—coronary artery disease	6.85e-05	0.000315	CcSEcCtD
Gatifloxacin—Hypersensitivity—Trandolapril—coronary artery disease	6.85e-05	0.000315	CcSEcCtD
Gatifloxacin—Dermatitis—Eplerenone—coronary artery disease	6.84e-05	0.000315	CcSEcCtD
Gatifloxacin—Diarrhoea—Valsartan—coronary artery disease	6.84e-05	0.000315	CcSEcCtD
Gatifloxacin—Confusional state—Timolol—coronary artery disease	6.83e-05	0.000315	CcSEcCtD
Gatifloxacin—Shock—Ramipril—coronary artery disease	6.82e-05	0.000314	CcSEcCtD
Gatifloxacin—Hypersensitivity—Enalapril—coronary artery disease	6.82e-05	0.000314	CcSEcCtD
Gatifloxacin—Body temperature increased—Perindopril—coronary artery disease	6.81e-05	0.000314	CcSEcCtD
Gatifloxacin—Abdominal pain—Perindopril—coronary artery disease	6.81e-05	0.000314	CcSEcCtD
Gatifloxacin—Palpitations—Lisinopril—coronary artery disease	6.81e-05	0.000313	CcSEcCtD
Gatifloxacin—Diarrhoea—Olmesartan—coronary artery disease	6.8e-05	0.000313	CcSEcCtD
Gatifloxacin—Headache—Eplerenone—coronary artery disease	6.8e-05	0.000313	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Ramipril—coronary artery disease	6.79e-05	0.000313	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Timolol—coronary artery disease	6.78e-05	0.000312	CcSEcCtD
Gatifloxacin—Oedema—Timolol—coronary artery disease	6.78e-05	0.000312	CcSEcCtD
Gatifloxacin—Pruritus—Pravastatin—coronary artery disease	6.77e-05	0.000312	CcSEcCtD
Gatifloxacin—Loss of consciousness—Lisinopril—coronary artery disease	6.77e-05	0.000312	CcSEcCtD
Gatifloxacin—Nausea—Clopidogrel—coronary artery disease	6.77e-05	0.000312	CcSEcCtD
Gatifloxacin—Tachycardia—Ramipril—coronary artery disease	6.76e-05	0.000312	CcSEcCtD
Gatifloxacin—Infection—Timolol—coronary artery disease	6.73e-05	0.00031	CcSEcCtD
Gatifloxacin—Vomiting—Simvastatin—coronary artery disease	6.73e-05	0.00031	CcSEcCtD
Gatifloxacin—Hypersensitivity—Telmisartan—coronary artery disease	6.72e-05	0.00031	CcSEcCtD
Gatifloxacin—Nausea—Lovastatin—coronary artery disease	6.72e-05	0.00031	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Ramipril—coronary artery disease	6.7e-05	0.000309	CcSEcCtD
Gatifloxacin—Rash—Simvastatin—coronary artery disease	6.67e-05	0.000307	CcSEcCtD
Gatifloxacin—Dermatitis—Simvastatin—coronary artery disease	6.67e-05	0.000307	CcSEcCtD
Gatifloxacin—Asthenia—Trandolapril—coronary artery disease	6.67e-05	0.000307	CcSEcCtD
Gatifloxacin—Shock—Timolol—coronary artery disease	6.67e-05	0.000307	CcSEcCtD
Gatifloxacin—Feeling abnormal—Losartan—coronary artery disease	6.66e-05	0.000307	CcSEcCtD
Gatifloxacin—Urticaria—Furosemide—coronary artery disease	6.65e-05	0.000306	CcSEcCtD
Gatifloxacin—Diarrhoea—Niacin—coronary artery disease	6.65e-05	0.000306	CcSEcCtD
Gatifloxacin—Asthenia—Enalapril—coronary artery disease	6.64e-05	0.000306	CcSEcCtD
Gatifloxacin—Headache—Simvastatin—coronary artery disease	6.63e-05	0.000305	CcSEcCtD
Gatifloxacin—Body temperature increased—Furosemide—coronary artery disease	6.62e-05	0.000305	CcSEcCtD
Gatifloxacin—Abdominal pain—Furosemide—coronary artery disease	6.62e-05	0.000305	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Losartan—coronary artery disease	6.61e-05	0.000304	CcSEcCtD
Gatifloxacin—Dizziness—Valsartan—coronary artery disease	6.61e-05	0.000304	CcSEcCtD
Gatifloxacin—Anorexia—Ramipril—coronary artery disease	6.61e-05	0.000304	CcSEcCtD
Gatifloxacin—Nausea—Ezetimibe—coronary artery disease	6.59e-05	0.000304	CcSEcCtD
Gatifloxacin—Dizziness—Olmesartan—coronary artery disease	6.58e-05	0.000303	CcSEcCtD
Gatifloxacin—Pruritus—Trandolapril—coronary artery disease	6.57e-05	0.000303	CcSEcCtD
Gatifloxacin—Chest pain—Lisinopril—coronary artery disease	6.56e-05	0.000302	CcSEcCtD
Gatifloxacin—Arthralgia—Lisinopril—coronary artery disease	6.56e-05	0.000302	CcSEcCtD
Gatifloxacin—Myalgia—Lisinopril—coronary artery disease	6.56e-05	0.000302	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Timolol—coronary artery disease	6.55e-05	0.000302	CcSEcCtD
Gatifloxacin—Asthenia—Telmisartan—coronary artery disease	6.55e-05	0.000302	CcSEcCtD
Gatifloxacin—Pruritus—Enalapril—coronary artery disease	6.55e-05	0.000302	CcSEcCtD
Gatifloxacin—Diarrhoea—Pravastatin—coronary artery disease	6.55e-05	0.000301	CcSEcCtD
Gatifloxacin—Anxiety—Lisinopril—coronary artery disease	6.53e-05	0.000301	CcSEcCtD
Gatifloxacin—Hypotension—Ramipril—coronary artery disease	6.48e-05	0.000298	CcSEcCtD
Gatifloxacin—Anorexia—Timolol—coronary artery disease	6.46e-05	0.000297	CcSEcCtD
Gatifloxacin—Pruritus—Telmisartan—coronary artery disease	6.46e-05	0.000297	CcSEcCtD
Gatifloxacin—Nausea—Eplerenone—coronary artery disease	6.45e-05	0.000297	CcSEcCtD
Gatifloxacin—Dizziness—Niacin—coronary artery disease	6.43e-05	0.000296	CcSEcCtD
Gatifloxacin—Urticaria—Losartan—coronary artery disease	6.42e-05	0.000296	CcSEcCtD
Gatifloxacin—Body temperature increased—Losartan—coronary artery disease	6.39e-05	0.000294	CcSEcCtD
Gatifloxacin—Abdominal pain—Losartan—coronary artery disease	6.39e-05	0.000294	CcSEcCtD
Gatifloxacin—Asthenia—Captopril—coronary artery disease	6.37e-05	0.000293	CcSEcCtD
Gatifloxacin—Diarrhoea—Trandolapril—coronary artery disease	6.36e-05	0.000293	CcSEcCtD
Gatifloxacin—Vomiting—Valsartan—coronary artery disease	6.35e-05	0.000293	CcSEcCtD
Gatifloxacin—Confusional state—Lisinopril—coronary artery disease	6.34e-05	0.000292	CcSEcCtD
Gatifloxacin—Diarrhoea—Enalapril—coronary artery disease	6.33e-05	0.000292	CcSEcCtD
Gatifloxacin—Hypotension—Timolol—coronary artery disease	6.33e-05	0.000292	CcSEcCtD
Gatifloxacin—Dizziness—Pravastatin—coronary artery disease	6.33e-05	0.000291	CcSEcCtD
Gatifloxacin—Vomiting—Olmesartan—coronary artery disease	6.32e-05	0.000291	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.31e-05	0.000291	CcSEcCtD
Gatifloxacin—Rash—Valsartan—coronary artery disease	6.3e-05	0.00029	CcSEcCtD
Gatifloxacin—Dermatitis—Valsartan—coronary artery disease	6.3e-05	0.00029	CcSEcCtD
Gatifloxacin—Nausea—Simvastatin—coronary artery disease	6.29e-05	0.00029	CcSEcCtD
Gatifloxacin—Oedema—Lisinopril—coronary artery disease	6.29e-05	0.000289	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Lisinopril—coronary artery disease	6.29e-05	0.000289	CcSEcCtD
Gatifloxacin—Pruritus—Captopril—coronary artery disease	6.28e-05	0.000289	CcSEcCtD
Gatifloxacin—Rash—Olmesartan—coronary artery disease	6.27e-05	0.000289	CcSEcCtD
Gatifloxacin—Insomnia—Ramipril—coronary artery disease	6.27e-05	0.000289	CcSEcCtD
Gatifloxacin—Dermatitis—Olmesartan—coronary artery disease	6.27e-05	0.000289	CcSEcCtD
Gatifloxacin—Headache—Valsartan—coronary artery disease	6.26e-05	0.000288	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—PPBP—coronary artery disease	6.26e-05	0.00105	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Telmisartan—coronary artery disease	6.24e-05	0.000288	CcSEcCtD
Gatifloxacin—Infection—Lisinopril—coronary artery disease	6.24e-05	0.000288	CcSEcCtD
Gatifloxacin—Headache—Olmesartan—coronary artery disease	6.23e-05	0.000287	CcSEcCtD
Gatifloxacin—Paraesthesia—Ramipril—coronary artery disease	6.22e-05	0.000287	CcSEcCtD
Gatifloxacin—Shock—Lisinopril—coronary artery disease	6.18e-05	0.000285	CcSEcCtD
Gatifloxacin—Asthenia—Perindopril—coronary artery disease	6.18e-05	0.000285	CcSEcCtD
Gatifloxacin—Dyspnoea—Ramipril—coronary artery disease	6.18e-05	0.000285	CcSEcCtD
Gatifloxacin—Vomiting—Niacin—coronary artery disease	6.18e-05	0.000285	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Timolol—coronary artery disease	6.17e-05	0.000284	CcSEcCtD
Gatifloxacin—Hypersensitivity—Furosemide—coronary artery disease	6.17e-05	0.000284	CcSEcCtD
Gatifloxacin—Somnolence—Ramipril—coronary artery disease	6.16e-05	0.000284	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—ITGA2B—coronary artery disease	6.15e-05	0.00104	CbGpPWpGaD
Gatifloxacin—Thrombocytopenia—Lisinopril—coronary artery disease	6.15e-05	0.000283	CcSEcCtD
Gatifloxacin—Dizziness—Trandolapril—coronary artery disease	6.14e-05	0.000283	CcSEcCtD
Gatifloxacin—Tachycardia—Lisinopril—coronary artery disease	6.13e-05	0.000283	CcSEcCtD
Gatifloxacin—Insomnia—Timolol—coronary artery disease	6.13e-05	0.000282	CcSEcCtD
Gatifloxacin—Rash—Niacin—coronary artery disease	6.13e-05	0.000282	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SLC27A1—coronary artery disease	6.13e-05	0.00103	CbGpPWpGaD
Gatifloxacin—Dermatitis—Niacin—coronary artery disease	6.12e-05	0.000282	CcSEcCtD
Gatifloxacin—Dizziness—Enalapril—coronary artery disease	6.12e-05	0.000282	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—KNG1—coronary artery disease	6.12e-05	0.00103	CbGpPWpGaD
Gatifloxacin—Dyspepsia—Ramipril—coronary artery disease	6.1e-05	0.000281	CcSEcCtD
Gatifloxacin—Pruritus—Perindopril—coronary artery disease	6.1e-05	0.000281	CcSEcCtD
Gatifloxacin—Headache—Niacin—coronary artery disease	6.09e-05	0.00028	CcSEcCtD
Gatifloxacin—Paraesthesia—Timolol—coronary artery disease	6.08e-05	0.00028	CcSEcCtD
Gatifloxacin—Vomiting—Pravastatin—coronary artery disease	6.08e-05	0.00028	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Lisinopril—coronary artery disease	6.08e-05	0.00028	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—HK2—coronary artery disease	6.08e-05	0.00102	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Captopril—coronary artery disease	6.07e-05	0.00028	CcSEcCtD
Gatifloxacin—Dyspnoea—Timolol—coronary artery disease	6.04e-05	0.000278	CcSEcCtD
Gatifloxacin—Dizziness—Telmisartan—coronary artery disease	6.04e-05	0.000278	CcSEcCtD
Gatifloxacin—Rash—Pravastatin—coronary artery disease	6.03e-05	0.000278	CcSEcCtD
Gatifloxacin—Dermatitis—Pravastatin—coronary artery disease	6.03e-05	0.000278	CcSEcCtD
Gatifloxacin—Decreased appetite—Ramipril—coronary artery disease	6.02e-05	0.000277	CcSEcCtD
Gatifloxacin—Somnolence—Timolol—coronary artery disease	6.02e-05	0.000277	CcSEcCtD
Gatifloxacin—Asthenia—Furosemide—coronary artery disease	6.01e-05	0.000277	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CPT1B—coronary artery disease	6.01e-05	0.00101	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LCAT—coronary artery disease	6.01e-05	0.00101	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—PTGS2—coronary artery disease	6e-05	0.00101	CbGpPWpGaD
Gatifloxacin—Headache—Pravastatin—coronary artery disease	5.99e-05	0.000276	CcSEcCtD
Gatifloxacin—Anorexia—Lisinopril—coronary artery disease	5.99e-05	0.000276	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—ATP2B1—coronary artery disease	5.97e-05	0.001	CbGpPWpGaD
Gatifloxacin—Dyspepsia—Timolol—coronary artery disease	5.96e-05	0.000275	CcSEcCtD
Gatifloxacin—Hypersensitivity—Losartan—coronary artery disease	5.95e-05	0.000274	CcSEcCtD
Gatifloxacin—Nausea—Valsartan—coronary artery disease	5.94e-05	0.000273	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PLG—coronary artery disease	5.93e-05	0.000997	CbGpPWpGaD
Gatifloxacin—Pruritus—Furosemide—coronary artery disease	5.93e-05	0.000273	CcSEcCtD
Gatifloxacin—Constipation—Ramipril—coronary artery disease	5.93e-05	0.000273	CcSEcCtD
Gatifloxacin—Nausea—Olmesartan—coronary artery disease	5.91e-05	0.000272	CcSEcCtD
Gatifloxacin—Vomiting—Trandolapril—coronary artery disease	5.91e-05	0.000272	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOA4—coronary artery disease	5.9e-05	0.000992	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Perindopril—coronary artery disease	5.9e-05	0.000272	CcSEcCtD
Gatifloxacin—Decreased appetite—Timolol—coronary artery disease	5.89e-05	0.000271	CcSEcCtD
Gatifloxacin—Vomiting—Enalapril—coronary artery disease	5.88e-05	0.000271	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—F3—coronary artery disease	5.88e-05	0.00099	CbGpPWpGaD
Gatifloxacin—Hypotension—Lisinopril—coronary artery disease	5.87e-05	0.00027	CcSEcCtD
Gatifloxacin—Dizziness—Captopril—coronary artery disease	5.87e-05	0.00027	CcSEcCtD
Gatifloxacin—Rash—Trandolapril—coronary artery disease	5.86e-05	0.00027	CcSEcCtD
Gatifloxacin—Dermatitis—Trandolapril—coronary artery disease	5.85e-05	0.00027	CcSEcCtD
Gatifloxacin—Rash—Enalapril—coronary artery disease	5.83e-05	0.000269	CcSEcCtD
Gatifloxacin—Dermatitis—Enalapril—coronary artery disease	5.83e-05	0.000268	CcSEcCtD
Gatifloxacin—ALB—Metabolism—CKMT1B—coronary artery disease	5.83e-05	0.000981	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	5.83e-05	0.00098	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ATP4A—coronary artery disease	5.83e-05	0.00098	CbGpPWpGaD
Gatifloxacin—Headache—Trandolapril—coronary artery disease	5.82e-05	0.000268	CcSEcCtD
Gatifloxacin—Vomiting—Telmisartan—coronary artery disease	5.8e-05	0.000267	CcSEcCtD
Gatifloxacin—Asthenia—Losartan—coronary artery disease	5.8e-05	0.000267	CcSEcCtD
Gatifloxacin—Headache—Enalapril—coronary artery disease	5.8e-05	0.000267	CcSEcCtD
Gatifloxacin—Nausea—Niacin—coronary artery disease	5.77e-05	0.000266	CcSEcCtD
Gatifloxacin—Rash—Telmisartan—coronary artery disease	5.75e-05	0.000265	CcSEcCtD
Gatifloxacin—Dermatitis—Telmisartan—coronary artery disease	5.75e-05	0.000265	CcSEcCtD
Gatifloxacin—Diarrhoea—Furosemide—coronary artery disease	5.73e-05	0.000264	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.73e-05	0.000264	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—SELL—coronary artery disease	5.72e-05	0.000963	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ANGPT2—coronary artery disease	5.72e-05	0.000963	CbGpPWpGaD
Gatifloxacin—Pruritus—Losartan—coronary artery disease	5.72e-05	0.000263	CcSEcCtD
Gatifloxacin—Headache—Telmisartan—coronary artery disease	5.72e-05	0.000263	CcSEcCtD
Gatifloxacin—Feeling abnormal—Ramipril—coronary artery disease	5.71e-05	0.000263	CcSEcCtD
Gatifloxacin—Dizziness—Perindopril—coronary artery disease	5.7e-05	0.000262	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PRKCE—coronary artery disease	5.7e-05	0.000959	CbGpPWpGaD
Gatifloxacin—Insomnia—Lisinopril—coronary artery disease	5.68e-05	0.000262	CcSEcCtD
Gatifloxacin—Nausea—Pravastatin—coronary artery disease	5.68e-05	0.000262	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SOD1—coronary artery disease	5.68e-05	0.000956	CbGpPWpGaD
Gatifloxacin—Gastrointestinal pain—Ramipril—coronary artery disease	5.67e-05	0.000261	CcSEcCtD
Gatifloxacin—Paraesthesia—Lisinopril—coronary artery disease	5.64e-05	0.00026	CcSEcCtD
Gatifloxacin—Vomiting—Captopril—coronary artery disease	5.64e-05	0.00026	CcSEcCtD
Gatifloxacin—Dyspnoea—Lisinopril—coronary artery disease	5.6e-05	0.000258	CcSEcCtD
Gatifloxacin—Rash—Captopril—coronary artery disease	5.6e-05	0.000258	CcSEcCtD
Gatifloxacin—Dermatitis—Captopril—coronary artery disease	5.59e-05	0.000257	CcSEcCtD
Gatifloxacin—Somnolence—Lisinopril—coronary artery disease	5.59e-05	0.000257	CcSEcCtD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL1B—coronary artery disease	5.58e-05	0.00094	CbGpPWpGaD
Gatifloxacin—Feeling abnormal—Timolol—coronary artery disease	5.58e-05	0.000257	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—SELP—coronary artery disease	5.58e-05	0.000938	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—F5—coronary artery disease	5.58e-05	0.000938	CbGpPWpGaD
Gatifloxacin—Headache—Captopril—coronary artery disease	5.56e-05	0.000256	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Timolol—coronary artery disease	5.54e-05	0.000255	CcSEcCtD
Gatifloxacin—Dizziness—Furosemide—coronary artery disease	5.54e-05	0.000255	CcSEcCtD
Gatifloxacin—Dyspepsia—Lisinopril—coronary artery disease	5.53e-05	0.000255	CcSEcCtD
Gatifloxacin—Diarrhoea—Losartan—coronary artery disease	5.53e-05	0.000255	CcSEcCtD
Gatifloxacin—Nausea—Trandolapril—coronary artery disease	5.52e-05	0.000254	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	5.52e-05	0.000928	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	5.52e-05	0.000928	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SLC8A1—coronary artery disease	5.51e-05	0.000927	CbGpPWpGaD
Gatifloxacin—Urticaria—Ramipril—coronary artery disease	5.51e-05	0.000254	CcSEcCtD
Gatifloxacin—Nausea—Enalapril—coronary artery disease	5.5e-05	0.000253	CcSEcCtD
Gatifloxacin—Vomiting—Perindopril—coronary artery disease	5.48e-05	0.000252	CcSEcCtD
Gatifloxacin—Abdominal pain—Ramipril—coronary artery disease	5.48e-05	0.000252	CcSEcCtD
Gatifloxacin—Body temperature increased—Ramipril—coronary artery disease	5.48e-05	0.000252	CcSEcCtD
Gatifloxacin—Decreased appetite—Lisinopril—coronary artery disease	5.46e-05	0.000252	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—GATA4—coronary artery disease	5.44e-05	0.000916	CbGpPWpGaD
Gatifloxacin—Rash—Perindopril—coronary artery disease	5.43e-05	0.00025	CcSEcCtD
Gatifloxacin—Dermatitis—Perindopril—coronary artery disease	5.43e-05	0.00025	CcSEcCtD
Gatifloxacin—Nausea—Telmisartan—coronary artery disease	5.42e-05	0.00025	CcSEcCtD
Gatifloxacin—Headache—Perindopril—coronary artery disease	5.4e-05	0.000249	CcSEcCtD
Gatifloxacin—Urticaria—Timolol—coronary artery disease	5.38e-05	0.000248	CcSEcCtD
Gatifloxacin—Constipation—Lisinopril—coronary artery disease	5.37e-05	0.000248	CcSEcCtD
Gatifloxacin—Body temperature increased—Timolol—coronary artery disease	5.36e-05	0.000247	CcSEcCtD
Gatifloxacin—Abdominal pain—Timolol—coronary artery disease	5.36e-05	0.000247	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	5.35e-05	0.000901	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	5.35e-05	0.000901	CbGpPWpGaD
Gatifloxacin—Dizziness—Losartan—coronary artery disease	5.34e-05	0.000246	CcSEcCtD
Gatifloxacin—Vomiting—Furosemide—coronary artery disease	5.33e-05	0.000245	CcSEcCtD
Gatifloxacin—Rash—Furosemide—coronary artery disease	5.28e-05	0.000243	CcSEcCtD
Gatifloxacin—Dermatitis—Furosemide—coronary artery disease	5.28e-05	0.000243	CcSEcCtD
Gatifloxacin—Nausea—Captopril—coronary artery disease	5.27e-05	0.000243	CcSEcCtD
Gatifloxacin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—coronary artery disease	5.25e-05	0.000884	CbGpPWpGaD
Gatifloxacin—Headache—Furosemide—coronary artery disease	5.25e-05	0.000242	CcSEcCtD
Gatifloxacin—Feeling abnormal—Lisinopril—coronary artery disease	5.18e-05	0.000239	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	5.17e-05	0.000869	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	5.17e-05	0.000869	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—P2RY12—coronary artery disease	5.15e-05	0.000867	CbGpPWpGaD
Gatifloxacin—Gastrointestinal pain—Lisinopril—coronary artery disease	5.14e-05	0.000237	CcSEcCtD
Gatifloxacin—Vomiting—Losartan—coronary artery disease	5.14e-05	0.000237	CcSEcCtD
Gatifloxacin—Nausea—Perindopril—coronary artery disease	5.12e-05	0.000236	CcSEcCtD
Gatifloxacin—Hypersensitivity—Ramipril—coronary artery disease	5.11e-05	0.000235	CcSEcCtD
Gatifloxacin—ALB—Platelet degranulation—VEGFA—coronary artery disease	5.1e-05	0.000859	CbGpPWpGaD
Gatifloxacin—ALB—Folate Metabolism—TNF—coronary artery disease	5.1e-05	0.000858	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—HGF—coronary artery disease	5.1e-05	0.000858	CbGpPWpGaD
Gatifloxacin—Rash—Losartan—coronary artery disease	5.1e-05	0.000235	CcSEcCtD
Gatifloxacin—Dermatitis—Losartan—coronary artery disease	5.09e-05	0.000234	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	5.08e-05	0.000854	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	5.08e-05	0.000854	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	5.08e-05	0.000854	CbGpPWpGaD
Gatifloxacin—Headache—Losartan—coronary artery disease	5.06e-05	0.000233	CcSEcCtD
Gatifloxacin—ALB—Vitamin B12 Metabolism—IL6—coronary artery disease	5.06e-05	0.000851	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CSF2—coronary artery disease	5.04e-05	0.000848	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	5.01e-05	0.000844	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	5.01e-05	0.000844	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—GNA12—coronary artery disease	5e-05	0.000842	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—THBD—coronary artery disease	5e-05	0.000842	CbGpPWpGaD
Gatifloxacin—Urticaria—Lisinopril—coronary artery disease	4.99e-05	0.00023	CcSEcCtD
Gatifloxacin—Hypersensitivity—Timolol—coronary artery disease	4.99e-05	0.00023	CcSEcCtD
Gatifloxacin—Nausea—Furosemide—coronary artery disease	4.98e-05	0.000229	CcSEcCtD
Gatifloxacin—Asthenia—Ramipril—coronary artery disease	4.97e-05	0.000229	CcSEcCtD
Gatifloxacin—Body temperature increased—Lisinopril—coronary artery disease	4.97e-05	0.000229	CcSEcCtD
Gatifloxacin—Abdominal pain—Lisinopril—coronary artery disease	4.97e-05	0.000229	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	4.95e-05	0.000834	CbGpPWpGaD
Gatifloxacin—Pruritus—Ramipril—coronary artery disease	4.9e-05	0.000226	CcSEcCtD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—coronary artery disease	4.86e-05	0.000818	CbGpPWpGaD
Gatifloxacin—Asthenia—Timolol—coronary artery disease	4.86e-05	0.000224	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	4.84e-05	0.000815	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—ITGB3—coronary artery disease	4.83e-05	0.000813	CbGpPWpGaD
Gatifloxacin—Nausea—Losartan—coronary artery disease	4.8e-05	0.000221	CcSEcCtD
Gatifloxacin—Pruritus—Timolol—coronary artery disease	4.79e-05	0.000221	CcSEcCtD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ABCG5—coronary artery disease	4.77e-05	0.000802	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	4.77e-05	0.000802	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—HK1—coronary artery disease	4.77e-05	0.000802	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—CD36—coronary artery disease	4.75e-05	0.0008	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CKM—coronary artery disease	4.75e-05	0.000799	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—UQCRFS1—coronary artery disease	4.75e-05	0.000799	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPAP2B—coronary artery disease	4.75e-05	0.000799	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Ramipril—coronary artery disease	4.74e-05	0.000218	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—SELE—coronary artery disease	4.74e-05	0.000798	CbGpPWpGaD
Gatifloxacin—ALB—Platelet degranulation—TGFB1—coronary artery disease	4.68e-05	0.000788	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	4.64e-05	0.000781	CbGpPWpGaD
Gatifloxacin—Diarrhoea—Timolol—coronary artery disease	4.64e-05	0.000214	CcSEcCtD
Gatifloxacin—Hypersensitivity—Lisinopril—coronary artery disease	4.63e-05	0.000213	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PRKCD—coronary artery disease	4.61e-05	0.000776	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ALDOA—coronary artery disease	4.59e-05	0.000773	CbGpPWpGaD
Gatifloxacin—Dizziness—Ramipril—coronary artery disease	4.58e-05	0.000211	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	4.55e-05	0.000766	CbGpPWpGaD
Gatifloxacin—Asthenia—Lisinopril—coronary artery disease	4.51e-05	0.000208	CcSEcCtD
Gatifloxacin—Dizziness—Timolol—coronary artery disease	4.48e-05	0.000206	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	4.47e-05	0.000752	CbGpPWpGaD
Gatifloxacin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—coronary artery disease	4.46e-05	0.000751	CbGpPWpGaD
Gatifloxacin—Pruritus—Lisinopril—coronary artery disease	4.45e-05	0.000205	CcSEcCtD
Gatifloxacin—ALB—Metabolism—ALDH6A1—coronary artery disease	4.42e-05	0.000743	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PYGM—coronary artery disease	4.42e-05	0.000743	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SULT4A1—coronary artery disease	4.42e-05	0.000743	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CKMT2—coronary artery disease	4.42e-05	0.000743	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PDK4—coronary artery disease	4.42e-05	0.000743	CbGpPWpGaD
Gatifloxacin—Vomiting—Ramipril—coronary artery disease	4.41e-05	0.000203	CcSEcCtD
Gatifloxacin—Rash—Ramipril—coronary artery disease	4.37e-05	0.000201	CcSEcCtD
Gatifloxacin—Dermatitis—Ramipril—coronary artery disease	4.37e-05	0.000201	CcSEcCtD
Gatifloxacin—Headache—Ramipril—coronary artery disease	4.34e-05	0.0002	CcSEcCtD
Gatifloxacin—Vomiting—Timolol—coronary artery disease	4.31e-05	0.000198	CcSEcCtD
Gatifloxacin—Diarrhoea—Lisinopril—coronary artery disease	4.3e-05	0.000198	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—CRK—coronary artery disease	4.28e-05	0.00072	CbGpPWpGaD
Gatifloxacin—Rash—Timolol—coronary artery disease	4.27e-05	0.000197	CcSEcCtD
Gatifloxacin—Dermatitis—Timolol—coronary artery disease	4.27e-05	0.000197	CcSEcCtD
Gatifloxacin—Headache—Timolol—coronary artery disease	4.24e-05	0.000195	CcSEcCtD
Gatifloxacin—ALB—Hemostasis—SH2B3—coronary artery disease	4.23e-05	0.000711	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ATP2A2—coronary artery disease	4.23e-05	0.000711	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—VWF—coronary artery disease	4.23e-05	0.000711	CbGpPWpGaD
Gatifloxacin—Dizziness—Lisinopril—coronary artery disease	4.16e-05	0.000191	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—APOA1—coronary artery disease	4.15e-05	0.000698	CbGpPWpGaD
Gatifloxacin—Nausea—Ramipril—coronary artery disease	4.12e-05	0.00019	CcSEcCtD
Gatifloxacin—ALB—Folate Metabolism—IL6—coronary artery disease	4.12e-05	0.000693	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—MAPK14—coronary artery disease	4.08e-05	0.000687	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—TNF—coronary artery disease	4.05e-05	0.000682	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SPARC—coronary artery disease	4.03e-05	0.000678	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—F2R—coronary artery disease	4.03e-05	0.000678	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—F7—coronary artery disease	4.03e-05	0.000678	CbGpPWpGaD
Gatifloxacin—Nausea—Timolol—coronary artery disease	4.02e-05	0.000185	CcSEcCtD
Gatifloxacin—Vomiting—Lisinopril—coronary artery disease	4e-05	0.000184	CcSEcCtD
Gatifloxacin—Rash—Lisinopril—coronary artery disease	3.96e-05	0.000183	CcSEcCtD
Gatifloxacin—Dermatitis—Lisinopril—coronary artery disease	3.96e-05	0.000182	CcSEcCtD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—F2—coronary artery disease	3.95e-05	0.000666	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—FN1—coronary artery disease	3.95e-05	0.000666	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IRF1—coronary artery disease	3.95e-05	0.000664	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—FGB—coronary artery disease	3.95e-05	0.000664	CbGpPWpGaD
Gatifloxacin—Headache—Lisinopril—coronary artery disease	3.94e-05	0.000181	CcSEcCtD
Gatifloxacin—ALB—Metabolism—HMGCS2—coronary artery disease	3.94e-05	0.000662	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GK—coronary artery disease	3.94e-05	0.000662	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LDHA—coronary artery disease	3.94e-05	0.000662	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GYG1—coronary artery disease	3.94e-05	0.000662	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PFKM—coronary artery disease	3.94e-05	0.000662	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GATM—coronary artery disease	3.94e-05	0.000662	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TGFB2—coronary artery disease	3.86e-05	0.00065	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	3.85e-05	0.000647	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	3.85e-05	0.000647	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	3.85e-05	0.000647	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—THBS1—coronary artery disease	3.85e-05	0.000647	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	3.82e-05	0.000643	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	3.8e-05	0.00064	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GCH1—coronary artery disease	3.76e-05	0.000632	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AK1—coronary artery disease	3.76e-05	0.000632	CbGpPWpGaD
Gatifloxacin—Nausea—Lisinopril—coronary artery disease	3.73e-05	0.000172	CcSEcCtD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	3.71e-05	0.000625	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	3.67e-05	0.000618	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	3.66e-05	0.000616	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLCD1—coronary artery disease	3.6e-05	0.000606	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MDH2—coronary artery disease	3.6e-05	0.000606	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPAT—coronary artery disease	3.6e-05	0.000606	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—UGCG—coronary artery disease	3.6e-05	0.000606	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TIMP1—coronary artery disease	3.59e-05	0.000605	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAT—coronary artery disease	3.59e-05	0.000605	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	3.57e-05	0.000601	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—CETP—coronary artery disease	3.53e-05	0.000594	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PGM1—coronary artery disease	3.47e-05	0.000583	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—IGF1—coronary artery disease	3.47e-05	0.000583	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	3.39e-05	0.00057	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	3.36e-05	0.000565	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CKB—coronary artery disease	3.35e-05	0.000563	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PYGB—coronary artery disease	3.35e-05	0.000563	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—TFRC—coronary artery disease	3.35e-05	0.000563	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—SERPINE1—coronary artery disease	3.29e-05	0.000554	CbGpPWpGaD
Gatifloxacin—ALB—Selenium Micronutrient Network—IL6—coronary artery disease	3.27e-05	0.00055	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ITGAV—coronary artery disease	3.16e-05	0.000532	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—KNG1—coronary artery disease	3.15e-05	0.000531	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—DLAT—coronary artery disease	3.15e-05	0.00053	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTM2—coronary artery disease	3.15e-05	0.00053	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—COX5B—coronary artery disease	3.15e-05	0.00053	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLIN1—coronary artery disease	3.15e-05	0.00053	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PFKFB3—coronary artery disease	3.15e-05	0.00053	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAUR—coronary artery disease	3.13e-05	0.000526	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—PLAT—coronary artery disease	3.11e-05	0.000523	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IFNA2—coronary artery disease	3.09e-05	0.00052	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLG—coronary artery disease	3.06e-05	0.000514	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—JAK2—coronary artery disease	3.05e-05	0.000514	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	2.99e-05	0.000503	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SULT1E1—coronary artery disease	2.98e-05	0.000502	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PRKCE—coronary artery disease	2.94e-05	0.000494	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SOD1—coronary artery disease	2.93e-05	0.000493	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	2.9e-05	0.000488	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HK2—coronary artery disease	2.85e-05	0.000479	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AKR1B1—coronary artery disease	2.85e-05	0.000479	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC27A1—coronary artery disease	2.73e-05	0.000459	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—APOB—coronary artery disease	2.7e-05	0.000455	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CPT1B—coronary artery disease	2.68e-05	0.00045	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LCAT—coronary artery disease	2.68e-05	0.00045	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—PLG—coronary artery disease	2.64e-05	0.000445	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—HGF—coronary artery disease	2.63e-05	0.000442	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOA4—coronary artery disease	2.63e-05	0.000442	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CSF2—coronary artery disease	2.6e-05	0.000437	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	2.58e-05	0.000434	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PDHA1—coronary artery disease	2.54e-05	0.000427	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GCLM—coronary artery disease	2.54e-05	0.000427	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—ITGB3—coronary artery disease	2.49e-05	0.000419	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	2.46e-05	0.000414	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP11B2—coronary artery disease	2.46e-05	0.000413	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—TXNRD1—coronary artery disease	2.46e-05	0.000413	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—CD36—coronary artery disease	2.45e-05	0.000412	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—HMOX1—coronary artery disease	2.44e-05	0.000411	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC22A3—coronary artery disease	2.42e-05	0.000407	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PPP2CA—coronary artery disease	2.42e-05	0.000407	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ARNTL—coronary artery disease	2.38e-05	0.000401	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HADH—coronary artery disease	2.38e-05	0.000401	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PRKCD—coronary artery disease	2.38e-05	0.0004	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	2.35e-05	0.000395	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—APOB—coronary artery disease	2.34e-05	0.000393	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	2.29e-05	0.000385	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—VEGFA—coronary artery disease	2.26e-05	0.000381	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOA2—coronary artery disease	2.26e-05	0.00038	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLA2G2A—coronary artery disease	2.26e-05	0.00038	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPX2—coronary artery disease	2.26e-05	0.00038	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MMP1—coronary artery disease	2.23e-05	0.000376	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HK1—coronary artery disease	2.23e-05	0.000376	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SULT1A1—coronary artery disease	2.23e-05	0.000376	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPX4—coronary artery disease	2.23e-05	0.000376	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCG5—coronary artery disease	2.23e-05	0.000376	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	2.23e-05	0.000375	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HADHA—coronary artery disease	2.21e-05	0.000371	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PLAU—coronary artery disease	2.19e-05	0.000369	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTA1—coronary artery disease	2.18e-05	0.000367	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LPA—coronary artery disease	2.16e-05	0.000363	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—APOA1—coronary artery disease	2.14e-05	0.00036	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MAPK14—coronary artery disease	2.1e-05	0.000354	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLCB3—coronary artery disease	2.09e-05	0.000352	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—TGFB1—coronary artery disease	2.08e-05	0.00035	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOA5—coronary artery disease	2.07e-05	0.000348	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—FN1—coronary artery disease	2.04e-05	0.000343	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—F2—coronary artery disease	2.04e-05	0.000343	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—MAPK1—coronary artery disease	2.04e-05	0.000343	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—P4HB—coronary artery disease	2.03e-05	0.000341	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS2—coronary artery disease	2.01e-05	0.000339	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	2.01e-05	0.000338	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLA2G1B—coronary artery disease	1.99e-05	0.000335	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.97e-05	0.000331	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.95e-05	0.000327	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—VCAN—coronary artery disease	1.88e-05	0.000316	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ALDOA—coronary artery disease	1.86e-05	0.000313	CbGpPWpGaD
Gatifloxacin—ALB—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.85e-05	0.000311	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—DCN—coronary artery disease	1.81e-05	0.000304	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—IGF1—coronary artery disease	1.79e-05	0.000301	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	1.77e-05	0.000298	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ALDH2—coronary artery disease	1.76e-05	0.000296	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.71e-05	0.000288	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HBA1—coronary artery disease	1.71e-05	0.000288	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LIPC—coronary artery disease	1.71e-05	0.000288	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CYP2C19—coronary artery disease	1.71e-05	0.000288	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3C2A—coronary artery disease	1.71e-05	0.000288	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOC3—coronary artery disease	1.7e-05	0.000287	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—SERPINE1—coronary artery disease	1.7e-05	0.000285	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LDLR—coronary artery disease	1.69e-05	0.000285	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.69e-05	0.000285	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTT1—coronary artery disease	1.67e-05	0.000281	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SLC9A1—coronary artery disease	1.67e-05	0.000281	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GCLC—coronary artery disease	1.65e-05	0.000278	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CETP—coronary artery disease	1.65e-05	0.000278	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—SDC1—coronary artery disease	1.63e-05	0.000275	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—NOS3—coronary artery disease	1.62e-05	0.000273	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—JAK2—coronary artery disease	1.57e-05	0.000265	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PSMB5—coronary artery disease	1.54e-05	0.00026	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PSMA6—coronary artery disease	1.54e-05	0.00026	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CTGF—coronary artery disease	1.51e-05	0.000254	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HMGCR—coronary artery disease	1.49e-05	0.000252	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GOT2—coronary artery disease	1.49e-05	0.000252	CbGpPWpGaD
Gatifloxacin—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	1.44e-05	0.000243	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PLCB1—coronary artery disease	1.37e-05	0.000231	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.35e-05	0.000227	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—ABCA1—coronary artery disease	1.33e-05	0.000224	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GGT1—coronary artery disease	1.29e-05	0.000217	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GOT1—coronary artery disease	1.29e-05	0.000217	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—VEGFA—coronary artery disease	1.17e-05	0.000196	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTP1—coronary artery disease	1.16e-05	0.000195	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPARGC1A—coronary artery disease	1.15e-05	0.000193	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—HMOX1—coronary artery disease	1.14e-05	0.000192	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CAT—coronary artery disease	1.13e-05	0.00019	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOB—coronary artery disease	1.09e-05	0.000184	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—TGFB1—coronary artery disease	1.07e-05	0.00018	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GSTM1—coronary artery disease	1.07e-05	0.000179	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—MAPK1—coronary artery disease	1.05e-05	0.000177	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—LPL—coronary artery disease	1.05e-05	0.000176	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—GPX1—coronary artery disease	1.02e-05	0.000172	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—CD36—coronary artery disease	9.93e-06	0.000167	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPP2CA—coronary artery disease	9.81e-06	0.000165	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—MTHFR—coronary artery disease	9.41e-06	0.000158	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—PIK3CA—coronary artery disease	9.11e-06	0.000153	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AGT—coronary artery disease	8.94e-06	0.000151	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOE—coronary artery disease	8.76e-06	0.000147	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—APOA1—coronary artery disease	8.66e-06	0.000146	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.3e-06	0.00014	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PPARG—coronary artery disease	7.63e-06	0.000128	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—POMC—coronary artery disease	7.53e-06	0.000127	CbGpPWpGaD
Gatifloxacin—ALB—Hemostasis—AKT1—coronary artery disease	7.44e-06	0.000125	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—NOS3—coronary artery disease	6.57e-06	0.00011	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PTGS2—coronary artery disease	6.01e-06	0.000101	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—PIK3CA—coronary artery disease	3.69e-06	6.22e-05	CbGpPWpGaD
Gatifloxacin—ALB—Metabolism—AKT1—coronary artery disease	3.02e-06	5.08e-05	CbGpPWpGaD
